LIVE: FDA Panel Discusses COVID-19 Vaccine Boosters, Potential Variant-Specific Shots

The Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration will meet in an open session to discuss considerations for use of COVID-19 vaccine booster doses and the process for COVID-19 vaccine strain selection to address current and emerging variants.